에서 실시간으로 운영 중이에요! 자세히 알아보기

Claritev Corp

CTEV

시가총액 US$3.75억

22.12 USD

-1.74

7.29%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

22.12

0.00

0%

1일

-7.29%

5일

-10.91%

1개월

-34.09%

3개월

-28.09%

6개월

12.57%

연초 이후

-34.73%

1년

-60.87%

5년

-88.48%

10년

-94.31%

소개: Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

직원 수: 3,000

건강관리 건강 정보 서비스

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 10.5%

중립 84.2%

부정적 5.3%

Claritev Appoints Jennifer Main to its Board of Directors

MCLEAN, Va., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Jennifer (Jenni) Main as a director, effective today, filling a newly created directorship on the Board.

Claritev Appoints Jennifer Main to its Board of Directors

Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call

MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, announced today that it will release its third quarter fiscal year 2026 financial results prior to market open on Monday, November 9, 2026, and hold a conference call at 8:00 am Eastern Time.

Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call

Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test

Claritev is showing early signs of a turnaround, with revenue and bookings growth supporting a Buy rating and a $34 price target (+40% upside). CTEV's 2027 earnings growth is critical, as high leverage (net debt $4.69B) and modest FCF ($5–15M in 2026) amplify financial risk. Revenue growth is concentrated in Claims Intelligence; broad-based margin recovery and operational leverage are needed to validate the investment thesis.

Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test

Claritev Selected by GDIT to Support CDC's World Trade Center Health Program

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #GDIT--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwid.

Claritev Selected by GDIT to Support CDC's World Trade Center Health Program

Claritev Releases 2025 Corporate Responsibility Report

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CommunityImpact--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report. The report highlights progress across Claritev's corporate responsibility priorities, including responsible AI, employee engagement, community impact, and sustainable operations. Throughout 2025, the Company remained focused on advancing transparency and affordability acros.

Claritev Releases 2025 Corporate Responsibility Report

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Claritev Appoints Ben Letham to its Board of Directors

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #BoardOfDirectors--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham's extensive experience in artificial intelligence (AI) will enhance the Board's depth of expertise and support the Company's long-term strategic objectives. Letham is a leader in AI and optimization.

Claritev Appoints Ben Letham to its Board of Directors

Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska. The grants will help address two very real barriers to ru.

Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

Claritev Corporation Announces Participation in Upcoming Events

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026: Wells Fargo 21st Annual Healthcare Conference – Wednesday, September 9, 2026, at the Encore Boston Harbor – one-on-one meetings J.P. Morgan 4th Annual Healthcare Credit Conference - Thursday, September 10, 2026, at The Joseph Nashv.

Claritev Corporation Announces Participation in Upcoming Events

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. Marpai currently uses Claritev's PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients' primary networks. The expanded agreement ex.

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.